Close

News

CENTOGENE and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19

CENTOGENE , a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, and the Cologne-based blockchain start-up Ubirch announced a joint solution for the successful fight...

Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing

Merck, a leading science and technology company, and The Jenner Institute announced that the Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19. With patients enrolled for clinical trials for this vaccine, rapid...

Moderna Gets $483M BARDA Deal for COVID-19 Vaccine

Moderna, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has entered an agreement for a commitment of up to $483 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office...

Roche develops new serology test to detect COVID-19 antibodies

Roche announced the development and upcoming launch of its Elecsys® Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes the COVID-19 disease. Antibody testing is central...

Kaneka Agrees to Supply Active Pharmaceutical Ingredients for Avigan Tablet

Kaneka Corporation (President: Minoru Tanaka) has reached an agreement with FUJIFILM Corporation (President: Kenji Sukeno) to supply drug substances for anti-influenza drug, Avigan® Tablet (general name: favipiravir), for the novel coronavirus disease (referred to below as COVID-19). While COVID-19 continues...

2020 CPhI Pharma Awards are Open for Entries

Best practices in the pharma and biotech industries will take centre stage at the 17th Annual CPhI Pharma Awards, powered by Informa Pharma Intelligence. Leaders and luminaries from across global pharma and biotech will recognize and honour the accomplishments...

Sygnature Discovery provides state-of-the-art liquid handling machine to UK Government’s COVID-19 testing efforts

Sygnature Group is supporting the Government’s COVID-19 testing strategy with the loan of a key piece of equipment. The machine, a Tecan Freedom EVO 100, will be used to help automate and accelerate the analysis of samples at the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »